This is an unrestricted procurement for Teriparatide Injection to supply the VA, DOD, BOP, and IHS, with the VA awarding a single contract to ensure an uninterrupted supply. The contract period is for one base year plus four pre-priced one-year option periods. The estimated annual requirement is 39,038 pens of the specified Teriparatide dosage. Items will be distributed through the VA and DOD Pharmaceutical Prime Vendor programs. The solicitation will be issued electronically on or about May 1, 2026.